Gut Microbiota-dependent Health Impacts of Haskap Berries
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Metabolic Disease, Inflammation, Microbial Colonization
In brief
Polyphenol-rich Haskap berries (Haskap) have untapped therapeutic potential to improve human health, and agricultural producers in northern U.S. states are poised to increase production if consumer demand increases. A critical knowledge gap is that little is known about the interactions between gut microbes and Haskap polyphenols to produce bioactive metabolites linked to downstream health impacts. Additionally, little is known about which Haskap varieties and harvest timing yield the greatest bioactive potential. This study aims to address these gaps by investigating the interaction of bioactive components in Haskap with gut microbiota and the resultant gut and serum metabolites, inflammation, and metabolic health, and then couple this with analysis of berries from different Haskap varieties and harvest times.
Key facts
- Study ID
- NCT06546020
- Run by
- Montana State University
- People needed
- 120
- Starts
- 2025-02-26
- Expected to finish
- 2028-05-01
- Last updated by the study team
- 2025-04-02
Who can join
Age: 35 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- BMI <18 or > 40 kg/m\^2
- potential allergy to Haskap or placebo ingredients
- use of anti-inflammatory, lipid lowering, glucose lowering, blood pressure, or any other medications that may interfere with study measures
- pregnant or lactating woman
- diagnosis with type 1 or type 2 diabetes or any other condition that may interfere with study measures
- smoke cigarettes
- have taken antibiotics in the past 90 days
- take supplements including pre/probiotics or "superfoods" within 30 days of starting the study
- are planning on starting a weight loss or exercise regiment change
- follow a specific diet such as low carbohydrate, vegan, and vegetarian
- consume over 5 servings of fruit/vegetables per day
- are unwilling to reduce caffeine intake to one 8 oz serving per day for the durations of the study
Where it is running
- Montana State University — Bozeman, Montana, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.